Which statement correctly matches BRCA1 and BRCA2 tumor subtypes?

Prepare for the CMID Test. Study with flashcards and multiple choice questions, each question contains hints and explanations. Get ready for your exam with confidence!

Multiple Choice

Which statement correctly matches BRCA1 and BRCA2 tumor subtypes?

Explanation:
Mutations in BRCA1 and BRCA2 tend to steer breast cancers toward different molecular patterns. BRCA1-associated tumors most often show a basal-like profile and lack hormone receptors, which classifies them as triple-negative breast cancers. This basal/TNBC phenotype reflects the gene-expression patterns typically seen when BRCA1 function is lost. BRCA2-associated tumors, in contrast, more commonly fall into the luminal category, especially luminal B. These cancers are usually estrogen receptor–positive and tend to have higher proliferation than luminal A tumors, fitting the luminal B subtype. So the statement pairing BRCA1 with basal/TNBC and BRCA2 with luminal B aligns with the common clinical-genetic patterns observed. There can be exceptions, but this is the general relationship.

Mutations in BRCA1 and BRCA2 tend to steer breast cancers toward different molecular patterns. BRCA1-associated tumors most often show a basal-like profile and lack hormone receptors, which classifies them as triple-negative breast cancers. This basal/TNBC phenotype reflects the gene-expression patterns typically seen when BRCA1 function is lost.

BRCA2-associated tumors, in contrast, more commonly fall into the luminal category, especially luminal B. These cancers are usually estrogen receptor–positive and tend to have higher proliferation than luminal A tumors, fitting the luminal B subtype.

So the statement pairing BRCA1 with basal/TNBC and BRCA2 with luminal B aligns with the common clinical-genetic patterns observed. There can be exceptions, but this is the general relationship.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy